價格 | ¥414 | ¥698 | ¥2470 |
包裝 | 5mg | 10mg | 50mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2025-03-12 |
中文名稱:布雷非德菌素 A | 英文名稱:Brefeldin A |
CAS:20350-15-6 | 品牌: TargetMol |
產(chǎn)地: 美國 | 保存條件: store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
純度規(guī)格: 99.90% | 產(chǎn)品類別: 抑制劑 |
貨號: T6062 |
名稱 | Brefeldin A |
描述 | Brefeldin A (Cyanein) belongs to the class of macrolide antibiotics and is an ATPase inhibitor (IC50=0.2 μM). Brefeldin A can induce tumor cell differentiation and apoptosis, and also possesses autophagy inhibitory activity. |
細胞實驗 | HF1A3, HF4.9 cell viability upon the treatments is tested using double staining of cells with YO-PRO 1/PI and SYTO16/PI probes. To access cell proliferation, cells are treated with 0–100 ng/mL Brefeldin A in complete medium for 20 hours before adding 1 μCi/mL [methyl-3H]-thymidine for additional 4 hours at 37 °C. The incorporated radioactive thymidine is quantified by scintillation counting with Microbeta counter. To examine long-term effects of Brefeldin A treatment, cells are seeded at initial concentration 105 cells/mL and treated with 0-75 ng/mL Brefeldin A for up to 5 days. At the time indicated, a sample of cells is removed and viable cell number is assessed by standard Trypan Blue exclusion assay.(Only for Reference) |
激酶實驗 | ELISA-based active site binding assay: Samples (lysed cells or tissue homogenates) are treated for 1 h at room temperature with the biotinylated active site probe PR-584 (5-15 μM). Samples are denatured by addition of SDS (0.9% final) and heating to 100 °C for 5 min. The denatured samples are transferred to a 96-well or 384-well filter plat, mixed with streptavidin-sepharose beads (2.5-5 μL packed beads/well), and incubated for 1 h at room temperature on a plate shaker. The beads are washed 5 times with 100-200 μL /well of ELISA buffer (PBS, 1% bovine serum albumin, 0.1% Tween-20) by vacuum filtration. The beads are incubated overnight at 4 °C on a plate shaker with the following antibodies recognizing the six catalytic subunits diluted into ELISA buffer: β5, β1, and β2 diluted 1:3000, LMP7 and LMP2 diluted 1:5000, and MECL-1 diluted 1:1000. The beads are washed 5 times with 100-200 μL /well of ELISA buffer and incubated with HRP-conjugated secondary antibody diluted 1:5000 in ELISA buffer and incubated 2 h at room temperature on a plate shaker. The beads are washed 5 times with 100-200 μL /well of ELISA buffer and developed for chemiluminsecence signal using the supersignal ELISA pico substrate following the manufacturer's instructions. Luminescence is measured on a plate reader and converted to ng of proteasome or μg/ml of lysate by comparison with 20S proteasome or untreated cell lysate standard curves. For proteasome inhibitor studies, active site probe binding values are expressed as the percent of binding relative to DMSO treated cells. |
體外活性 | 方法:腫瘤細胞 HL60 、K562 和 HT-29 用 Brefeldin A (2 μM) 處理 72 h,使用 DNA filter elution assay 檢測 DNA 片段。 結(jié)果:Brefeldin A 以不同的動力學誘導 DNA 斷裂。HL60 細胞在 15 h 內(nèi)觀察到完整的 DNA 片段,而 K562 和 HT-29 細胞則需要 48-72 h。[1] 方法:人乳腺癌細胞 MDA-MB-231 用 Brefeldin A (0.05-1 μg/mL) 處理 24 h,使用 Western Blot 方法檢測靶點蛋白表達水平。 結(jié)果:PARP 切割是細胞死亡的標志性事件,可以在 Brefeldin A 處理的懸浮 MDA-MB-231 細胞中檢測到。[2] |
體內(nèi)活性 | 方法:為檢測體內(nèi)抗腫瘤活性,將 Brefeldin A (15 mg/kg in 10% ricinus oil+5% DMSO+10% ethanol+75% physiologic saline) 腹腔注射給攜帶人結(jié)直腸癌腫瘤 HCT116 的 BALB/c 小鼠,每天一次,持續(xù)四周。 結(jié)果:Brefeldin A 在體內(nèi)抑制 HCT116 腫瘤生長。[3] 方法:為檢測體內(nèi)抗腫瘤活性,將 Brefeldin A (16-64 mg/kg in distilled water containing 0.05% Tween 80) 腹腔注射給攜帶腫瘤 LOX IMVI 的 Athymic NCr nu/nu 小鼠,每天兩次,持續(xù)五天。 結(jié)果:Brefeldin A 在體內(nèi)顯示出抗腫瘤活性,小鼠壽命增加 65%-100%,第 60 天幸存者增加 17%-50%。[4] |
存儲條件 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
溶解度 | Ethanol : 2.8 mg/mL (9.99 mM), Sonication is recommended. DMSO : 100 mg/mL (356.68 mM), Sonication is recommended. |
關(guān)鍵字 | Mitophagy | Mitochondrial Autophagy | Inhibitor | inhibit | HSV | Herpes simplex virus | CRISPR/Cas9 | CRISPR | Cas9 | Brefeldin A | Autophagy | ATPase (HCT 116) | Antibiotic |
相關(guān)產(chǎn)品 | Sodium orthovanadate | Naringin | Cysteamine hydrochloride | Alginic acid | Doxycycline | Neomycin sulfate | Terbinafine hydrochloride | Hydroxychloroquine | Stavudine | Sulfamethoxazole sodium | Paeonol | Kanamycin sulfate |
相關(guān)庫 | 抑制劑庫 | 抗癌活性化合物庫 | 經(jīng)典已知活性庫 | 已知活性化合物庫 | 藥食同源庫 | 抗癌天然產(chǎn)物庫 | 抗病毒庫 | 免疫/炎癥分子化合物庫 | 膜蛋白靶向化合物庫 | 中藥抗炎分子庫 | 高通量篩選天然產(chǎn)物庫 | 抗感染天然產(chǎn)物庫 |
成立日期 | 2013-04-18 (13年) | 注冊資本 | 566.2651萬人民幣 |
員工人數(shù) | 100-500人 | 年營業(yè)額 | ¥ 1億以上 |
主營行業(yè) | 化學試劑,生物活性小分子 | 經(jīng)營模式 | 貿(mào)易,試劑,定制,服務 |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
詢價 |
VIP10年
|
湖北威德利化學科技有限公司
|
2025-08-14 | |
詢價 |
VIP9年
|
武漢維斯爾曼生物工程有限公司
|
2025-08-14 | |
詢價 |
VIP5年
|
武漢鼎信通藥業(yè)有限公司
|
2025-08-14 | |
¥526 |
VIP4年
|
湖北魏氏化學試劑股份有限公司
|
2025-08-14 | |
詢價 |
VIP4年
|
湖北魏氏化學試劑股份有限公司
|
2025-08-14 | |
¥660.00 |
VIP10年
|
北京索萊寶科技有限公司
|
2025-08-13 | |
詢價 |
VIP6年
|
陜西締都醫(yī)藥化工有限公司
|
2025-08-08 | |
詢價 |
VIP4年
|
湖北辰心藥業(yè)有限公司
|
2025-08-08 | |
詢價 |
VIP4年
|
武漢艾美捷科技有限公司
|
2025-08-08 | |
¥756 |
VIP4年
|
湖北魏氏化學試劑股份有限公司
|
2025-08-08 |